Abnormal uterine bleeding as first symptom of acute promyelocytic leukaemia: a case report and literature review
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20251590Keywords:
Uterine bleeding, Haematological cancer, Acute promyelocytic leukemia, Subarachnoid haemorrhageAbstract
Abnormal uterine bleeding is common within gynaecology practice. It affects up to one-third of women during their lifetime. Hematological cancer is a rare form of coagulopathy leading to abnormal uterine bleeding. Uterine bleeding caused by coagulopathy as a complication of acute promyelocytic leukaemia can be fatal. The aim was to document a rare case of acute severe abnormal uterine bleeding as first symptom of haematological cancer (Acute Promyelocytic Leukaemia). She was a 45-year-old Para 2 woman who presented at the emergency room with chief complaint of uterine bleeding of six days duration. She also developed a throbbing headache that suddenly intensified, initially on the left side of her head, radiating to the periorbital area. Assessment of Acute promyelocytic Leukaemia complicated by Subarachnoid haemorrhage was made. She was referred to National Hospital Abuja for further management. Uterine bleeding caused by coagulopathy as a complication of acute promyelocytic leukaemia can be life threatening, hence early diagnosis and treatment is imperative.
Metrics
References
Nebgen DR, Rhodes HE, Hartman C, Munsell MF, Lu KH. Abnormal uterine Bleeding as the presenting symptom of Hematologic Cancer. Obstet Gynecol. 2016;128(2):257-362. DOI: https://doi.org/10.1097/AOG.0000000000001529
Singh S, Best C, Dunn S, Leyland N, Wolfman WL. Abnormal uterine bleeding in premenopausal women. J Obstet Gynecol Can. 2013;35(5):473-5. DOI: https://doi.org/10.1016/S1701-2163(15)30939-7
Matteson KA, Raker CA, Clark MA, Frick KD. Abnormal uterine bleeding, health status, and usual source of medical care: analyses using the Medical Expenditures Panel Survey. Journal of women’s health (Larchmt). 2013;22(11):959-65. DOI: https://doi.org/10.1089/jwh.2013.4288
Wouk N, Helton M. Abnormal Uterine Bleeding in premenopausal women. Am Fam Phys. 2019;99(7):435-43.
Bodur S, Ayaz Y, Topallar F, Erdem G, Gun İ. Severe uterine haemorrhage as first manifestation of acute leukemia. Eastern J Med. 2011;62-5.
Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM COEIN) for causes of abnormal uterine bleeding in non-gravid women of reproductive age. International J Obst Gynecol. 2011;113:3-13. DOI: https://doi.org/10.1016/j.ijgo.2010.11.011
Okafor LC, Ogoke NC, Taiwo WO, Adagadzu SJ, Iseko KI, Meraiyebu AE. Abnormal Uterine Bleeding due to Retention of Fetal bones after Abortion: A case report. Open J Obst Gynaecol. 2023;13:1881-5. DOI: https://doi.org/10.4236/ojog.2023.1311159
Mishra K, Muralidaran C, Jandial A, Mittal BR, Varma S. Uterine mass and menorrhagia: a rare presentation of acute myeloid leukemia with arduous clinical course. Balkan Med J. 2018;35(3):282-4. DOI: https://doi.org/10.4274/balkanmedj.2017.0941
Blaicher W, Jager U. Abnormal vaginal bleeding as first symptom of acute leukemia. Arch Gynecol Obst. 2001;265(1):55-6. DOI: https://doi.org/10.1007/s004040000130
Prabhu TRB. Promyelocytic Leukemia presenting as acute haemorrhage. South Asian Fed Obst and Gynecol. 2010;2(3):220-1. DOI: https://doi.org/10.5005/jp-journals-10006-1104
Tsagkas N, Troussa A, Vorgias G, Tzaida O, Zagorianakou N, Gonidi M. Extramedullary Leukemia Presenting at the Cervix of the Uterus. Case Reports in Obstetrics and Gynecology. Case Rep Obstet Gynecol. 2020;2020:8492036. DOI: https://doi.org/10.1155/2020/8492036
Henes M, Nauth A, Staebler A, Becker S, Henes JC. Postmenopausal bleeding as first manifestation of an acute myelogenous Leukemia: A case report and review of literature. Med Oncol. 2010;27(3):815-9. DOI: https://doi.org/10.1007/s12032-009-9291-z
Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002;99:759-67. DOI: https://doi.org/10.1182/blood.V99.3.759
Test for acute myeloid leukemia (AML). American Cancer Society. Avaialble at: https://www.cancer.org/cancer. Assessed on 30 January 2024.
Hajjar KA, Acharya SS. Annexin II and regulation of cell surface fibrinolysis. Ann N Y Acad Sci 2000;902:265-71. DOI: https://doi.org/10.1111/j.1749-6632.2000.tb06321.x
Tallman MS, Andersen JW, Schiffer CA. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup Protocol. Blood 2002;100:4298-302. DOI: https://doi.org/10.1182/blood-2002-02-0632
Sanz MA, Lo-Coco F. Modern approaches to treating acute myelocytic leukemia. J Clin Oncol. 2011;29(5):1067. DOI: https://doi.org/10.1200/JCO.2010.32.1067
Gill H, Raghupathy R, Lee CY. Acute Promyelocytic leukemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021. BMC Cancer. 2023;141:2885-93. DOI: https://doi.org/10.1186/s12885-023-10612-z
Naymagon L, Mascarenhas J. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented. Leu Res. 2020;94:106356. DOI: https://doi.org/10.1016/j.leukres.2020.106356
Abedin S, Altman JK. Acute promyelocytic leukemia: preventing early complications and late toxicities. Hematology Am Soc Hematol Educ Program. 2016(1):10-5. DOI: https://doi.org/10.1182/asheducation-2016.1.10
Downloads
Published
How to Cite
Issue
Section
